VICTORIA SUKHOLUTSKY: Open Payments
NPI 1922399294 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 36 payments from 15 companies in 2025. Trend: 2023 $1,636 · 2024 $851 · 2025 $1,280
Food & beverage: $1,257Education: $23
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 2 | $200 |
| Adaptive Biotechnologies Corporation | 3 | $173 |
| Astellas Pharma US Inc | 4 | $128 |
| Novartis Pharmaceuticals Corporation | 4 | $124 |
| AstraZeneca Pharmaceuticals LP | 4 | $123 |
| SOBI, INC | 4 | $118 |
| GlaxoSmithKline, LLC. | 4 | $104 |
| Lilly USA, LLC | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
Products named: clonoSEQ, SCEMBLIX, Vonjo, OJJAARA, CALQUENCE, Xospata, Cresemba, JAYPIRCA.
Industry payments across TX — which companies pay providers there.
